China cancer man denounced for using US$97,000 donations to buy flat, hiding family wealth
Sick university graduate pleaded poverty but wealthy family had property portfolio, crowdfunding platform bans him as result.
InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...